Literature DB >> 15373923

Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.

M Holland1, P Hewins, M Goodall, D Adu, R Jefferis, C O S Savage.   

Abstract

A characteristic feature of Wegener's granulomatosis is the presence of antineutrophil cytoplasm antibodies (ANCA) to proteinase 3 (PR3). In vitro, ANCA activate neutrophils by co-ligating PR3 and FcgammaRIIa/IIIb receptors. ANCA are predominantly of the IgG isotype, and IgG1, IgG3 and IgG4 subclasses are particularly represented. To address the pathogenic role of individual ANCA-IgG subclass antibodies, patients' sera were screened using indirect immunofluorescence, enzyme-linked immunosorbent assay (ELISA) and subclass PR3-ELISA to identify patients with high titres of PR3-ANCA within the IgG1, IgG3 or IgG4 subclasses. Unfractionated ANCA-IgG and subclass fractions were isolated by affinity chromatography and compared for their capacities to stimulate superoxide production by primed human neutrophils. Donor neutrophils were analysed for constitutive and induced FcgammaRI expression by flow cytometry. The IgG1, IgG3 and IgG4 subclass fractions, isolated from three different ANCA sera, each stimulated superoxide production from neutrophils derived from multiple donors. Subsequently, IgG4 subclass fractions isolated from a further four ANCA positive sera demonstrated varying abilities to stimulate release of superoxide; unrelated to PR3-ANCA titre, neutrophil donor, or neutrophil FcgammaRI expression. The stimulation of superoxide release by IgG1- and IgG3-ANCA subclass fractions is consistent with the proposed mechanism of co-ligation of PR3 antigen and FcgammaRIIa/IIIb receptors. However, the demonstration of similar activity for the IgG4-ANCA subclass fractions isolated from some sera was unexpected. This activity was independent of neutrophil donor and expression of FcgammaRI, suggesting it was capable of activating neutrophils via constitutively expressed FcgammaRIIa/IIIb or co-ligation of other, unidentified, cell surface molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373923      PMCID: PMC1809192          DOI: 10.1111/j.1365-2249.2004.02566.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

Review 1.  Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.

Authors:  G Gaskin; C D Pusey
Journal:  Ther Apher       Date:  2001-06

2.  ANCA-associated renal vasculitis.

Authors:  C O Savage
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

3.  Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition.

Authors:  E J Campbell; M A Campbell; C A Owen
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

4.  Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.

Authors:  L Harper; P Cockwell; D Adu; C O Savage
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

5.  IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.

Authors:  L Harper; D Radford; T Plant; M Drayson; D Adu; C O Savage
Journal:  Arthritis Rheum       Date:  2001-04

6.  The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation.

Authors:  D J Radford; J M Lord; C O Savage
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis.

Authors:  R Nowack; I Grab; L F Flores-Suarèz; P Schnülle; B Yard; F J van der Woude
Journal:  Nephrol Dial Transplant       Date:  2001-08       Impact factor: 5.992

Review 8.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

Authors:  J Savige; D Gillis; E Benson; D Davies; V Esnault; R J Falk; E C Hagen; D Jayne; J C Jennette; B Paspaliaris; W Pollock; C Pusey; C O Savage; R Silvestrini; F van der Woude; J Wieslander; A Wiik
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

9.  Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation.

Authors:  A Ben-Smith; S K Dove; A Martin; M J Wakelam; C O Savage
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

10.  Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

Authors:  M M Boomsma; C A Stegeman; M J van der Leij; W Oost; J Hermans; C G Kallenberg; P C Limburg; J W Tervaert
Journal:  Arthritis Rheum       Date:  2000-09
View more
  35 in total

1.  IgG2m4, an engineered antibody isotype with reduced Fc function.

Authors:  Zhiqiang An; Gail Forrest; Renee Moore; Michael Cukan; Peter Haytko; Lingyi Huang; Salvatore Vitelli; Jing Zhang Zhao; Ping Lu; Jin Hua; Christopher R Gibson; Barrett R Harvey; Donna Montgomery; Dennis Zaller; Fubao Wang; William Strohl
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

Review 2.  Laboratory investigation in the diagnosis of vasculitis.

Authors:  Luis Felipe Flores-Suárez
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

3.  Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.

Authors:  T Pankhurst; G Nash; J Williams; R Colman; A Hussain; C Savage
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

Review 4.  Immunology of IgG4-related disease.

Authors:  E Della-Torre; M Lanzillotta; C Doglioni
Journal:  Clin Exp Immunol       Date:  2015-06-08       Impact factor: 4.330

5.  A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis.

Authors:  Hironori Bando; Genzo Iguchi; Hidenori Fukuoka; Masaaki Taniguchi; Seiji Kawano; Miki Saitoh; Kenichi Yoshida; Ryusaku Matsumoto; Kentaro Suda; Hitoshi Nishizawa; Michiko Takahashi; Akio Morinobu; Eiji Kohmura; Wataru Ogawa; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

Review 6.  Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature.

Authors:  Hirotoshi Kawashima; Atsunari Utsugi; Asuka Shibamiya; Kazuma Iida; Norihiro Mimura; Hirohumi Ohashi; Ryota Hase; Makio Kawakami; Takao Yanagisawa; Masaki Hiraguri
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 7.  IgG4-associated vasculitis.

Authors:  Rodolfo Perez Alamino; Carlos Martínez; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 8.  The safety and side effects of monoclonal antibodies.

Authors:  Trevor T Hansel; Harald Kropshofer; Thomas Singer; Jane A Mitchell; Andrew J T George
Journal:  Nat Rev Drug Discov       Date:  2010-03-22       Impact factor: 84.694

9.  Membranous glomerulonephritis with crescents.

Authors:  Caroline M F Barrett; Megan L Troxell; Christopher P Larsen; Donald C Houghton
Journal:  Int Urol Nephrol       Date:  2013-11-12       Impact factor: 2.370

Review 10.  Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.